401 related articles for article (PubMed ID: 26384952)
1. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.
Lo CC; Davidson WS; Hibbard SK; Georgievsky M; Lee A; Tso P; Woods SC
Endocrinology; 2014 May; 155(5):1700-7. PubMed ID: 24564397
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy.
Ripken D; van der Wielen N; van der Meulen J; Schuurman T; Witkamp RF; Hendriks HF; Koopmans SJ
Physiol Behav; 2015 Feb; 139():167-76. PubMed ID: 25449395
[TBL] [Abstract][Full Text] [Related]
4. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
[TBL] [Abstract][Full Text] [Related]
5. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
6. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
Corp ES; Curcio M; Gibbs J; Smith GP
Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
[TBL] [Abstract][Full Text] [Related]
7. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin.
Cox JE; Kelm GR; Meller ST; Randich A
Physiol Behav; 2004 Aug; 82(1):27-33. PubMed ID: 15234586
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.
Eisen S; Phillips RJ; Geary N; Baronowsky EA; Powley TL; Smith GP
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R456-R462. PubMed ID: 15831770
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
10. NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation.
Guard DB; Swartz TD; Ritter RC; Burns GA; Covasa M
Brain Res; 2009 Apr; 1266():37-44. PubMed ID: 19232331
[TBL] [Abstract][Full Text] [Related]
11. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin.
Moran TH; Baldessarini AR; Salorio CF; Lowery T; Schwartz GJ
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1245-51. PubMed ID: 9140026
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.
Lo CC; Langhans W; Georgievsky M; Arnold M; Caldwell JL; Cheng S; Liu M; Woods SC; Tso P
Endocrinology; 2012 Dec; 153(12):5857-65. PubMed ID: 23027805
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
Hayes MR; Savastano DM; Covasa M
Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
[TBL] [Abstract][Full Text] [Related]
14. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
Viard E; Zheng Z; Wan S; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
[TBL] [Abstract][Full Text] [Related]
15. Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats.
Schwartz GJ; Plata-Salamán CR; Langhans W
Am J Physiol; 1997 Sep; 273(3 Pt 2):R1193-8. PubMed ID: 9321903
[TBL] [Abstract][Full Text] [Related]
16. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.
Burdyga G; Lal S; Varro A; Dimaline R; Thompson DG; Dockray GJ
J Neurosci; 2004 Mar; 24(11):2708-15. PubMed ID: 15028763
[TBL] [Abstract][Full Text] [Related]
17. Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4.
Labouesse MA; Stadlbauer U; Weber E; Arnold M; Langhans W; Pacheco-López G
J Neuroendocrinol; 2012 Dec; 24(12):1505-16. PubMed ID: 22827554
[TBL] [Abstract][Full Text] [Related]
18. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
Peters JH; Simasko SM; Ritter RC
Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
[TBL] [Abstract][Full Text] [Related]
19. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
[TBL] [Abstract][Full Text] [Related]
20. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
Gourcerol G; Wang L; Wang YH; Million M; Taché Y
Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
